4-year MRes + PhD studentships in Cancer Biology within the Cancer Research UK Cambridge Centre

Cancer Research UK Cambridge Centre has a fully-funded innovative MRes + PhD programme, designed to give students a broad understanding of both the basic biology and the clinical management of the whole spectrum of malignant disease.

The CRUK Cambridge Centre is a dynamic collaboration of academic researchers, clinicians, and the pharmaceutical and biotech industries based in the Cambridge area. More than 700 laboratory researchers and physicians are united through a 12 programme structure with the research being supported by a state-of-the-art research environment including:

  • World-class research facilities for basic and clinical research
  • Nationally and internationally recognised centres of excellence – e.g. Early Cancer Detection and Precision Cancer Medicine.
  • Outstanding opportunities to translate fundamental scientific discoveries to benefit patients with cancer.

The MRes degree comprises of two research rotations, a weekly lecture series, a week of intensive teaching in genomic medicine, and a two-week placement in a patient-facing setting. Project write-ups, oral presentations and development of a PhD proposal are integral to the programme. Successful completion of the one-year MRes programme will lead directly on to a fully-funded three-year PhD, usually in one of the rotation project host laboratories.

Five CRUK Cambridge Centre MRes + PhD studentships are available for non-clinical applicants, to commence in October 2022. Support includes a generous stipend at £19,000 per annum, research costs and fees at the Home rate. There is funding available from the Cambridge Trust to uplift the tuition fees for one successful EU or overseas applicant.

There are a number of different programmes and projects available, including several in the Early Detection field.

For more information and to apply online, please visit the CRUK Cambridgeshire Centre Studentship webpage.

The deadline for applications is 15th November 2021.